Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 14

Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis

Authors Kalantar-Zadeh K, Ficociello LH, Bazzanella J, Mullon C, Anger MS

Received 10 November 2020

Accepted for publication 30 December 2020

Published 20 January 2021 Volume 2021:14 Pages 11—21

DOI https://doi.org/10.2147/IJNRD.S291348

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Pravin Singhal


Kamyar Kalantar-Zadeh,1– 3 Linda H Ficociello,4 Jennifer Bazzanella,5 Claudy Mullon,4 Michael S Anger4

1Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine, School of Medicine, Orange, CA, USA; 2Department of Epidemiology, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; 3Los Angeles Biomedical Research Institute at Harbor–UCLA, Torrance, CA, USA; 4Fresenius Medical Care Renal Therapies Group, Waltham, MA, USA; 5Fresenius Kidney Care, Madison, WI, USA

Correspondence: Kamyar Kalantar-Zadeh
Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine Medical Center, 101 the City Drive South, Orange, CA 92868-3217, USA
Tel +1-714-456-5142
Fax +1-714-456-6034
Email kkz@uci.edu

Abstract: Hypoalbuminemia results when compensatory mechanisms are unable to keep pace with derangements in catabolism/loss and/or decreased synthesis of albumin. Across many disease states, including chronic kidney disease (CKD), hypoalbuminemia is a well-established, independent risk factor for adverse outcomes, including mortality. In the setting of CKD, reduced serum albumin concentrations are often a manifestation of protein-energy wasting, a state of metabolic and nutritional alterations resulting in reduced protein and energy stores. The progression of CKD to kidney failure and the initiation of maintenance hemodialysis (HD) further predisposes an already at-risk population toward hypoalbuminemia such that approximately 60% of HD patients have albumin concentrations < 4.0 g/dl. Albumin loss into the dialysate through the dialyzer appears to be a potentially modifiable cause of hypoalbuminemia in some patients. A group of newer dialyzers for maintenance HD—sometimes termed protein-leaking or medium cut-off membranes—aim to improve clearance of middle molecules (vs high flux dialyzers) but are associated with increased albumin losses. In this article, we will examine the impact of dialyzer selection on albumin losses during conventional HD, including the clinical relevance of such losses on serum albumin levels. Data on the clinical relevance of albumin losses during dialysis and current gaps in the evidence base are also discussed.

Keywords: dialysis membrane, dialyzer, nutrition, hemodialysis, protein-energy wasting

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]